- Home
- PRME vs MUJ Comparison
PRME vs MUJ Comparison
Compare PRME & MUJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRME
- MUJ
- Stock Information
- Founded
- PRME 2019
- MUJ 1998
- Country
- PRME United States
- MUJ United States
- Employees
- PRME N/A
- MUJ N/A
- Industry
- PRME Medicinal Chemicals and Botanical Products
- MUJ Investment Bankers/Brokers/Service
- Sector
- PRME Health Care
- MUJ Finance
- Exchange
- PRME Nasdaq
- MUJ Nasdaq
- Market Cap
- PRME 624.0M
- MUJ 589.8M
- IPO Year
- PRME 2022
- MUJ N/A
- Fundamental
- Price
- PRME $3.72
- MUJ $11.08
- Analyst Decision
- PRME Buy
- MUJ
- Analyst Count
- PRME 6
- MUJ 0
- Target Price
- PRME $8.88
- MUJ N/A
- AVG Volume (30 Days)
- PRME 3.0M
- MUJ 108.0K
- Earning Date
- PRME 08-07-2025
- MUJ 01-01-0001
- Dividend Yield
- PRME N/A
- MUJ 4.36%
- EPS Growth
- PRME N/A
- MUJ N/A
- EPS
- PRME N/A
- MUJ N/A
- Revenue
- PRME $4,961,000.00
- MUJ N/A
- Revenue This Year
- PRME $179.58
- MUJ N/A
- Revenue Next Year
- PRME N/A
- MUJ N/A
- P/E Ratio
- PRME N/A
- MUJ N/A
- Revenue Growth
- PRME 739.42
- MUJ N/A
- 52 Week Low
- PRME $1.11
- MUJ $9.74
- 52 Week High
- PRME $5.17
- MUJ $11.70
- Technical
- Relative Strength Index (RSI)
- PRME 54.32
- MUJ 57.54
- Support Level
- PRME $3.09
- MUJ $10.88
- Resistance Level
- PRME $3.49
- MUJ $11.13
- Average True Range (ATR)
- PRME 0.25
- MUJ 0.09
- MACD
- PRME 0.01
- MUJ -0.00
- Stochastic Oscillator
- PRME 95.49
- MUJ 86.54
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
About MUJ Blackrock MuniHoldings New Jersey Quality Fund Inc.
BlackRock MuniHoldings New Jersey Quality Fund Inc is a closed-end management investment company. The investment objective of the company is to provide shareholders with current income exempt from U.S. federal income tax and New Jersey personal income taxes. The fund invests in a portfolio of long-term, investment-grade New Jersey municipal obligations.